NCT06624800

Brief Summary

This study is a double blind, randomized controlled trail. condition/disease: Patient with acute shoulder pain and restricted movement due to a traffic accident. treatment/intervention: Chuna therapy for the shoulder, including integrated Korean medicine treatment

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

November 4, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2025

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

September 26, 2024

Last Update Submit

March 23, 2026

Conditions

Keywords

shoulder chuna therapy

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale(NRS) of Shoulder pain

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their shoulder pain and discomfort using NRS, where 0 indicates \'no pain or discomfort\' and 10 indicates \'the most severe pain and discomfort imaginable\'.

    Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment

Secondary Outcomes (6)

  • Location of shoulder joint displacement

    Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment

  • Shoulder Pain intensity scale: Visual Analogue Scale (VAS)

    From baseline(Day2) up to Discharge 1 day

  • Physical examination (Shoulder active range of motion)

    From baseline(Day2) up to Discharge 1 day

  • Shoulder Pain and Disability Index(SPADI)

    From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment

  • EuroQol 5-Dimension (EQ-5D)

    From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment

  • +1 more secondary outcomes

Study Arms (2)

Shoulder chuna treatment

EXPERIMENTAL

During the hospitalization period, Chuna therapy for the shoulder joint will be performed once a day for a total of 10 to 15 minutes, including before, during, and after the treatment. The practitioner will assess the condition and select one of three techniques-posterior displacement, anterior displacement, or lateral displacement-to apply Chuna therapy

Procedure: Korean medical treatment

Korean medical treatment

ACTIVE COMPARATOR

The control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: Shoulder chuna treatment(posterior displacement, anterior displacement, or lateral displacement)Procedure: Korean medical treatment

Interventions

The Shoulder Chuna therapy for the shoulder joint will be performed on the affected shoulder from the second day of hospitalization until the day before discharge.

Korean medical treatment

acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine

Korean medical treatmentShoulder chuna treatment

Eligibility Criteria

Age19 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 19-69 years on the date they sign the consent form.
  • Patients with shoulder pain and restricted movement occurring within 5 days after a traffic accident.
  • Patients who are hospitalized due to traffic accident.
  • Patients with NRS of shoulder pain ≥ 5 with restricted movement due to a traffic accident.
  • Patients who provide consent to participate in the trial and return the informed consent form.

You may not qualify if:

  • Patients with a specific serious disease that may cause shoulder pain: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms.
  • Patients with medical history of cervical surgery or shoulder surgery within the last three weeks.
  • Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
  • Chuna therapy is deemed inappropriate or unsafe due to conditions like fractures, dislocations, ligament tears, or unstable healing fractures; skeletal demineralization and ligament laxity with subluxation or dislocation; or inflammation
  • Presence of other chronic diseases that could interfere with treatment outcomes or interpretation, such as cardiovascular disease, kidney disease, diabetic neuropathy, dementia, or epilepsy
  • Currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study results
  • Acupuncture is deemed inappropriate or unsafe, such as in patients with bleeding disorders, those on anticoagulant therapy, those with severe diabetes prone to infection, or those with severe cardiovascular disease
  • Patients who are pregnant or planning to become pregnant.
  • Patients who are presence of severe mental illness
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement.
  • Other patients whose participation in the trial is judged by a researcher to be problematic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

Location

Study Officials

  • In-Hyuk Ha, phD

    Jaseng Medical Foundation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2024

First Posted

October 3, 2024

Study Start

November 4, 2024

Primary Completion

July 5, 2025

Study Completion

November 10, 2025

Last Updated

March 27, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations